cn3
Thursday 25 August 2016
The EpiPen Controversy Isn't About Mylan
Political outrage over EpiPen price increases won’t help lower health-care costs for Americans.
from WSJ.com: Markets http://ift.tt/2brLCw2
via https://ifttt.com/ IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment